According to Royalty Pharma's latest financial reports and stock price the company's current number of shares outstanding is 448,439,000. At the end of 2023 the company had 448,439,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 0.44 B | 2.08% |
2022 | 0.43 B | 2.58% |
2021 | 0.42 B | 10.33% |
2020 | 0.38 B | 9.59% |
2019 | 0.35 B |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Abbott Laboratories ABT | 1,734,076,358 | 286.69% | ๐บ๐ธ USA |
Eli Lilly LLY | 949,379,000 | 111.71% | ๐บ๐ธ USA |
ANI Pharmaceuticals ANIP | 18,883,000 | -95.79% | ๐บ๐ธ USA |